Follow-The-Filings

Holders · period archive

TNGX · Tango Therapeutics Inc.

Q2 2022 13F holders among managers we track latest ownership dossier

Ticker
TNGX
Type
Equity
Class
COM
Total reported value ($000, long equity)
Manager Report date Value Shares